BioCentury
ARTICLE | Clinical News

Xencor preclinical data

December 22, 2008 8:00 AM UTC

Data from cynomolgus monkeys showed that XmAb5574 was well tolerated and elicited immediate and sustained B cell depletion in a dose-dependent manner. The humanized mAb, which targets the CD19 antige...